Effects of a bacterial immunomodulator on the level of serum proinflammatory cytokines in patients with psoriasis

Gorskiĭ V.S.; Tishchenko A.L.; Rudneva N.S.

doi:https://doi.org/

Gorskiĭ V.S.

GUZ Tul'skiĭ oblastnoĭ kozhno-venerologicheskiĭ dispanser

Tishchenko A.L.

Rossiĭskiĭ universitet druzhby narodov, Moskva

Rudneva N.S.

GUZ Tul'skiĭ oblastnoĭ kozhno-venerologicheskiĭ dispanser

Effects of a bacterial immunomodulator on the level of serum proinflammatory cytokines in patients with psoriasis

Authors:

Gorskiĭ V.S., Tishchenko A.L., Rudneva N.S.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2012;10(6): 75‑79

Read: 1704 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gorskiĭ VS, Tishchenko AL, Rudneva NS. Effects of a bacterial immunomodulator on the level of serum proinflammatory cytokines in patients with psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2012;10(6):75‑79. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

References:

Skripkin Yu.K., Bogush P.G., Kruglova L.S., Dvornikov A.S. Novye vozmozhnosti naruzhnoi terapii psoriaza. Vestn dermatol i venerol 2006;3:33-36.
Sampogna F., Chren M.M., Melchi C.F. et al. Age, sex, quality of life and psychological distress at the patients hospitalized concerning a psoriasis. Br Dermatol J 2006;154 (2):325-331.
Katunina O.R. Sravnitel'naya immunomorfologicheskaya kharakteristika kletok vospalitel'nogo infil'trata pri psoriaze i bolezni Deverzhi. Vestn poslediplomn med obraz 2005;1:15.
Korotkii N.G., Udzhukhu V.Yu., Abdullaeva A.E. i dr. Kompleksnaya immunomoduliruyushchaya terapiya bol'nykh psoriazom. Ros zhurn kozhn i ven bol 2001;1:14-16.
Malenkova K.M. Izmeneniya nekotorykh biokhimicheskikh pokazatelei krovi pri vozdeistvii rentgenovskikh luchei. Vestn rentgenol i radiol 1958;3:74.
Dimon-Gadal S., Gerbaud P., Therond P. et al. Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J Invest Dermatol 2000;114(5):984-989.
Austin L.M., Coven T.R., Bhardwaj N. et al. Intra-epidermal lymphocytes in psoriatic lesions are activated GMP-17 (TIA-1)+CD8+CD3+CDLs as determined by phenotypic analysis. J Cutan Pathol 1998;125:79-88.
Tereshin K.Ya. Osobennosti techeniya psoriaza v usloviyakh Dal'nego Vostoka i razrabotka metodov ego prognozirovaniya i korrigiruyushchei terapii. Avtoref. dis. … dokt. med. nauk. M 2004:33.
Korotkii N.G. Pervyi opyt primeneniya anti-FNO-α (remikeid) pri lechenii tyazhelo protekayushchego psoriaza. Vestn dermatol i venerol 2003;4:35-36.
Dovzhanskii S.I. Psoriaz: rol' provotsiruyushchikh faktorov. I Rossiiskii s''ezd dermatovenerologov. Tezisy dokladov. Spb 2003;1:36.
Gottlieb A., Masud S., Ramamurthi R. et al. Infliximab monotherapy normalizes keratynocyte differentiation and decreases inflammation in skin biopsies from patients with moderate to severe plaque psoriasis. 20th world congress dermatology, 1-5.07.2002. Paris 2002;1756.
Gromova A.Yu., Chaplygin A.V., Samtsov A.V. i dr. Razlichie pokazatelei vospalitel'nogo otveta v kozhe pri rasprostranennom vul'garnom psoriaze i psoriaticheskom artrite. Ros. zhurn. kozhn. i ven. bol. 2005;5:23-27.